In summary, our study using publicly available GWAS summary data and MR analysis has identified causal associations between 17 systemic inflammatory modulators and CKD outcomes, including bidirectional associations between GROα and SCF levels and renal function impairment. This evidence concerns the gene CXCL1 and chronic kidney disease.